| Polarized Reflectance Spectroscopy for Oral Lesions (NCT01604759) | British Columbia Cancer Agency | 2011-12-01 |
| Subcutaneous Lidocaine For Cancer-Related Pain (NCT01384877) | British Columbia Cancer Agency | 2011-12-01 |
| Innovative Approach to Triage Oral Precancer (NCT03202810) | British Columbia Cancer Agency | 2011-11-15 |
| Pilot Study of Partial Breast Irradiation Utilizing Permanent Breast Seed Implant to Treat Breast Cancer (NCT01191164) | British Columbia Cancer Agency | 2011-09-01 |
| Feasibility of VMAT and CBCT for Head and Neck Carcinomas (NCT01384890) | British Columbia Cancer Agency | 2011-07-01 |
| Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap Smear (NCT00610662) | British Columbia Cancer Agency | 2010-12-01 |
| CT-validation of Ultrasound Based Planning for High Dose Rate (HDR) Prostate Brachytherapy Using Vitesse (NCT01248741) | British Columbia Cancer Agency | 2010-12-01 |
| Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia (NCT00602368) | British Columbia Cancer Agency | 2010-12-01 |
| Acupuncture for the Immune System in Radiation Cancer Patients (NCT01422928) | British Columbia Cancer Agency | 2010-12-01 |
| PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer (NCT00816582) | British Columbia Cancer Agency | 2010-11-30 |
| Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate (NCT01174017) | British Columbia Cancer Agency | 2010-09-01 |
| OGX-427 in Castration Resistant Prostate Cancer Patients (NCT01120470) | British Columbia Cancer Agency | 2010-09-01 |
| Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients (NCT01189409) | British Columbia Cancer Agency | 2010-06-01 |
| (Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer (NCT02627703) | British Columbia Cancer Agency | 2010-05-01 |
| A Trial Testing Professional and Peer-led Support Online Support Groups for Young Canadian Breast Cancer Survivors (NCT01089699) | British Columbia Cancer Agency | 2010-04-01 |
| Volumetric Modulated Arc Therapy (VMAT) for Brain Metastases (NCT01046123) | British Columbia Cancer Agency | 2010-01-01 |
| Biomarker - Panitumumab Response With KRAS Wild Type MCC (NCT00853931) | British Columbia Cancer Agency | 2009-10-01 |
| Can 3D Ultrasound Be Used Reproducibly by Radiation Therapists in Partial Breast Image-Guided Radiation Therapy (NCT00911456) | British Columbia Cancer Agency | 2009-10-01 |
| Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer. (NCT00757692) | British Columbia Cancer Agency | 2009-01-01 |
| Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer (NCT00473083) | British Columbia Cancer Agency | 2009-01-01 |
| Intraprostatic MAXimal Simultaneous Boost (NCT00798837) | British Columbia Cancer Agency | 2008-12-01 |
| Screening Methods in Finding Lung Cancer Early in Current or Former Smokers (NCT00751660) | British Columbia Cancer Agency | 2008-09-01 |
| Evaluation of the Informational Content of Setup Verification Images for Patients Receiving Breast Radiation Therapy (Anterior EPI) (NCT00800189) | British Columbia Cancer Agency | 2008-08-01 |
| A Randomized Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer (NCT00615420) | British Columbia Cancer Agency | 2008-07-01 |
| The Bowel Research Collaborative Data Tracking System Implementation Study (NCT00728975) | British Columbia Cancer Agency | 2008-06-01 |
| Neuropathic Pain Caused by Radiation Therapy (NCT00798083) | British Columbia Cancer Agency | 2008-04-01 |
| Bone Health in Gynecologic Cancers-does FOSAVANCE Help? (NCT00593580) | British Columbia Cancer Agency | 2008-02-01 |
| Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum (NCT00573885) | British Columbia Cancer Agency | 2008-01-01 |
| Do Skin Markings Reflect the Location of the Surgical Cavity During Daily Radiotherapy Treatment? (NCT00578747) | British Columbia Cancer Agency | 2008-01-01 |
| Randomized Anastrozole Exercise Trial (NCT00519883) | British Columbia Cancer Agency | 2007-12-01 |
| Study of Tumour Response to Tirapazamine During Treatment of Cervical Cancer (NCT00493376) | British Columbia Cancer Agency | 2007-08-01 |
| Acupuncture in Palliative Cancer Care (NCT00302185) | British Columbia Cancer Agency | 2007-06-01 |
| Intensity Modulated Versus Interstitial - Radiation Therapy (NCT00407875) | British Columbia Cancer Agency | 2007-03-01 |
| A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer (NCT00430235) | British Columbia Cancer Agency | 2007-03-01 |
| Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy (NCT00407251) | British Columbia Cancer Agency | 2007-02-01 |
| Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol (NCT00569712) | British Columbia Cancer Agency | 2007-01-01 |
| Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer (NCT00371553) | British Columbia Cancer Agency | 2006-11-01 |
| Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia (NCT00611650) | British Columbia Cancer Agency | 2006-10-01 |
| Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial (NCT00386828) | British Columbia Cancer Agency | 2006-10-01 |
| Gene Expression Profiling of Cervical Cancer Progression in Biopsies and Tissue Samples (NCT00629577) | British Columbia Cancer Agency | 2006-09-01 |
| Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment (NCT00324467) | British Columbia Cancer Agency | 2006-08-01 |
| 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology (NCT00207298) | British Columbia Cancer Agency | 2005-06-01 |
| Identifying Biomarkers for Early Detection of Cancer in Patients With Cervical Dysplasia or Carcinoma in Situ of the Cervix (NCT00601601) | British Columbia Cancer Agency | 2004-12-01 |
| The Use of Silver Leaf Dressing in the Prevention of Radiotherapy Induced Skin Reactions (NCT00207324) | British Columbia Cancer Agency | 2004-01-01 |
| Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma (NCT00070083) | British Columbia Cancer Agency | 2003-07-01 |
| Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers (NCT00061997) | British Columbia Cancer Agency | 2003-05-01 |
| ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia (NCT00522197) | British Columbia Cancer Agency | 2002-09-01 |
| Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia (NCT00005880) | British Columbia Cancer Agency | 2000-07-01 |
| Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing Colposcopy (NCT00632190) | British Columbia Cancer Agency | 2000-01-01 |
| Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN) (NCT00627835) | British Columbia Cancer Agency | |
| 18F-FDOPA PET in Neuroendocrine Tumours (NCT02431715) | British Columbia Cancer Agency | |
| 18F-FDG PET Imaging in Cardiac Sarcoidosis (NCT01764191) | British Columbia Cancer Agency | |